Premium
Excess death estimates in patients with end‐stage renal disease — United States, February–August 2020
Author(s) -
Ziemba Robert,
Campbell Kyle N.,
Yang TsuHsuan,
Schaeffer Sara E.,
Mayo Kelly M.,
McGann Paul,
Quinn Shalon,
Roach Jesse,
Huff Edwin D.
Publication year - 2021
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.16041
Subject(s) - medicine , end stage renal disease , pandemic , dialysis , kidney transplantation , immunosuppression , covid-19 , excess mortality , confounding , population , transplantation , disease , demography , mortality rate , infectious disease (medical specialty) , environmental health , sociology
This article describes an estimated 6953–10 316 excess deaths among individuals with end‐stage renal disease during the early months of the COVID‐19 pandemic in February 2020–August 2020 (compared to death rates prior to the pandemic). Notably, the estimated number of excess deaths was reported as 10.8–16.6 per 1000 individuals on dialysis and 2.6–5.5 per 1000 individuals with a prior kidney transplantation. Although not adjusted for confounders, these data suggest that the immunosuppression associated with kidney transplantation is not a dominant determinant of outcomes associated with COVID‐19 in this population.